Jobs / United States / Glaxosmithkline LLC
Field Vice President, Market Access Oncology Strategic Accounts - Central
Glaxosmithkline LLC · 🇺🇸 8 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles1 certified filing for “Sr Manager - Oncology Commercial Analytics, Multiple Myeloma” (Data Scientists) in PA: $135k–$135k, median $135k. Most were filed at wage level III (100%) — 3 lottery entries, ≈46% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
The territory for this region includes Florida, Georgia, Tennessee, Alabama, Michigan, Ohio, Minnesota and Illinois. GSK ONCOLOGY GSK is a place to build a career in Oncology where purpose, science and growth come together. As a focused, global biopharma company, we unite science, technology, and talent to get ahead of disease together — with a clear ambition to deliver impact for patients at scale. For people looking to make a difference, that means joining a company with the capabilities, investment and momentum to translate innovation into meaningful improvements in patient outcomes — and to do it as part of a business entering a sustained period of growth. GSK Oncology is building real momentum — advancing a growing portfolio of approved medicines while investing in a pipeline designed to redefine cancer care. Recent progress, including approvals in endometrial cancer and multiple myeloma, alongside targeted business development to expand into areas such as lung cancer, reflects a business that is delivering today while building for the future. What sets GSK apart is the combination of scientific depth and culture. With substantial investment in R&D, a broad development pipeline, expertise in genetics and advanced technologies, and a strong partnership model, GSK offers the opportunity to work at the forefront of innovation. Just as importantly, GSK is a place where people can thrive. Our culture is grounded in being ambitious for patients, accountable for impact, and committed to doing the right thing — creating an environment where individuals are supported to grow and contribute at their full potential. For talent in Oncology, GSK offers the opportunity to be part of a science‑led, high‑growth business — contributing to work that is shaping the future of cancer care and making a meaningful difference for patients. ROLE SUMMARY As Field Vice President, Market Access Field Oncology Strategic Accounts, you will lead a team of regional Strategic Oncology Account Directors who shape and execute GSK’s oncology strategy across health systems, cancer centers, and community oncology accounts. You will be accountable for coaching and developing your team to influence clinical and economic decision makers, ensuring integrated brand, access, and account strategies that deliver market-leading growth. You will lead all regional oncology strategic account activities in decision making, account planning, access strategy pull-through, and population-based decision maker engagement. You will initiate, develop, and support the implementation of opportunities for company expansion in oncology, support brand volume and market share targets, demonstrate a strong focus on account and region performance and long-term opportunities. This role will give you the opportunity to lead key activities to progress GSK’s oncology industry leadership and your career. KEY RESPONSIBILITIES • Lead, coach, and develop a regional team of Strategic Oncology Account Directors responsible for priority health system cancer centers, national free-standing cancer centers, and organized community oncology customers. You will set clear expectations, provide actionable feedback, and build account leadership skills within your team. • Support in-field engagement, develop and maintain trusted relationships with key C/D-Suite Population Based Decision Makers (PBDM) across the region’s key academic cancer centers and large community oncology practice networks. • Direct the Strategic Oncology Account Directors in the development and execution of GSK’s go-to-market model within targeted community oncology, health system accounts, and leading cancer centers across the region, partnering closely with Oncology commercial field teams. • Partner with cros